浙江省806例急性心肌梗死患者药物治疗状况的调查  

Cross-sectional survey of characteristics and therapeutic status of 806 patients with acute myocardial infarction in Zhejiang Province

作　　者：胡晓晟[1] 姚雪艳[1] 陈君柱[1] 朱建华[1] 唐叶民[1] 

机构地区：[1]浙江大学医学院附属第一医院心内科,杭州310003

出　　处：《中华急诊医学杂志》2006年第11期1024-1027,共4页Chinese Journal of Emergency Medicine

基　　金：浙江省卫生厅科研基金资助项目(491010-w-10338)

摘　　要：目的 了解2001～2002年浙江省急性心肌梗死（AMI）患者的药物治疗状况。方法 调查浙江省23所医院2001-2002年间出院诊断为AMI的806份病史资料。结果 男性占72．2％。平均年龄为67．4岁，从胸痛发生至到达医院平均时间为11h。总静脉溶栓率仅为19．2％，适宜溶栓却未进行溶栓治疗者106例（45．9％），β受体阻滞剂（BB）和血管紧张素转换酶抑制剂（ACEI）的实际使用率分别为49．4％、65．4％。阿斯匹林、低分子肝素、他汀类使用率较高，分别为88．2％、73．7％、71．5％。结论 浙江省的AMI西医药治疗基本上遵循了指南推荐策略，但与指南要求仍存在差距，尤其是静脉溶栓率偏低。Objective To investigate the characteristics and treatment of patients with acute myocardial infarction （AMI） in Zhejiang Province. Methods The cross-sectional and retrospective survey was conducted during January 1, 2001 to December 31, 2002. Hospitalized patients with discharge diagnosis of AMI were included from 23 collaborating hospitals in Zhejiang Province. Results Medical records of 806 hospitalized patients with diagnosis of AMI were collected. Among these patients, 72.2% were male, mean age was 67.4 years old, and median time from the onset of chest pain to the arrival of hospital was 11 hours. The rate of intravenous thrombolytic therapy was 19.2% . One hundred and six eligible patients （45.9%） did not receive thrombolysis therapy. The actual utilization rate of beta blockers （BB） and angiotensin - converting enzyme inhibitors （ACEI） was 49.4% and 65.4% , respectively. The use rate of aspirin, low molecularweight heparin and statins was 88.2%, 73.7% and 71.5% , respectively. Conclusion The guidelines of AHA/ACC were implemented in the treatment of AMI in Zhejiang Province. However, the use rate of intravenous thrombolysis was still low.

关 键 词：心肌梗死 急性 溶栓治疗 药物治疗 横断面调查 

分 类 号：R542.22[医药卫生—心血管疾病]